Belite Bio Analyst Ratings
BenzingaMar 22 23:12
Buy Rating Affirmed on Belite Bio as Tinlarebant Shows Promising Clinical Advancements and Market Potential
TipRanksMar 22 21:25
Buy Rating Justified for Belite Bio, Inc. ADR Amidst Promising DRAGON Trial Progress and Strong Financials
TipRanksMar 21 14:16
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arcellx Inc (ACLX) and AdaptHealth (AHCO)
TipRanksMar 18 19:10
Analysts' Top Healthcare Picks: Belite Bio, Inc. ADR (BLTE), Catalyst Pharma (CPRX)
TipRanksMar 14 19:40
Belite Bio Analyst Ratings
BenzingaMar 13 18:56
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Belite Bio, Inc. ADR (BLTE) and Prothena (PRTA)
TipRanksMar 13 18:20
Belite Bio Analyst Ratings
BenzingaDec 28, 2023 00:43
Maxim Group Initiates Coverage On Belite Bio With Buy Rating, Announces Price Target of $60
BenzingaDec 14, 2023 22:11
Belite Bio Analyst Ratings
BenzingaDec 14, 2023 22:10
Belite Bio's Promising Outlook: Strong 3Q23 Results, Effective STGD1 Treatment & Solid Financial Standing Drive Buy Rating
TipRanksNov 16, 2023 20:20
Belite Bio, Inc. ADR (BLTE) Gets a Buy From Benchmark Co.
TipRanksNov 15, 2023 20:08
Belite Bio Analyst Ratings
BenzingaNov 15, 2023 20:04
Promising Clinical Trials and Stable Financials Bolster Buy Rating for Belite Bio, Inc. ADR
TipRanksNov 15, 2023 19:27
Belite Bio, Inc. Receives Buy Rating Amid Promising Tinlarebant Trial Results and Increased Profitability Forecast
TipRanksNov 8, 2023 13:33
Benchmark Reiterates Buy on Belite Bio, Maintains $57 Price Target
BenzingaNov 8, 2023 01:18
Belite Bio Analyst Ratings
BenzingaNov 8, 2023 01:17
HC Wainwright & Co. Maintains Buy on Belite Bio, Raises Price Target to $59
BenzingaNov 7, 2023 00:46
Belite Bio Analyst Ratings
BenzingaNov 7, 2023 00:43
Analysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Sanofi (SNYNF)
TipRanksOct 30, 2023 19:01
No Data
No Data